Low Dose Vaccine Study for Surgically Resected Pancreatic Cancer

NCT00614601 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

9

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor proceeded with a phase III study for same indication.

Conditions

Pancreatic Cancer

Interventions

BIOLOGICAL: HyperAcute(R)-Pancreatic Cancer Vaccine

Sponsor

NewLink Genetics Corporation